SG 00529 is primarily utilized in the field of pharmaceutical research, where it serves as a potent and selective inhibitor of specific protein kinases. Its application is crucial in the study of cellular signaling pathways, particularly those involved in cancer progression. Researchers employ SG 00529 to investigate the mechanisms of kinase activity and to evaluate its potential as a therapeutic agent in targeted cancer treatments. Additionally, it is used in preclinical studies to assess its efficacy and safety in inhibiting tumor growth, making it a valuable tool in the development of novel anticancer drugs.